ENDRA Life Sciences (NDRA) Net Cash Flow Growth (3y) (2019 - 2026)
ENDRA Life Sciences (NDRA) Net Cash Flow Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 89.23% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 45.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.69% |
| Dec 31, 2025 | 78.36% |
| Sep 30, 2025 | 32.24% |
| Jun 30, 2025 | -27.28% |
| Mar 31, 2025 | 20.69% |
| Dec 31, 2024 | 13.37% |
| Sep 30, 2024 | 9.72% |
| Jun 30, 2024 | 57.15% |
| Mar 31, 2024 | -29.60% |
| Dec 31, 2023 | -28.98% |
| Sep 30, 2023 | -35.50% |
| Jun 30, 2023 | 44.97% |
| Mar 31, 2023 | 6.21% |
| Dec 31, 2022 | -40.98% |
| Sep 30, 2022 | -649.88% |
| Jun 30, 2022 | 65.14% |
| Mar 31, 2022 | 2.85% |
| Dec 31, 2021 | -33.88% |
| Sep 30, 2021 | -12.78% |
| Jun 30, 2021 | -43.66% |